Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA).
Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA). We aim at improving the quality of life of patients with RA by creating imaging devices that support the rheumatologist in monitoring and treatment of this disease.Its devices are based on the patented Optical Inflammation Detection technology, a non-invasive, fast and objective method that supports rheumatologists in the quantification of inflammation, a key parameter in the treatment of patients with RA.Hemics was founded as a spin-out of Royal Philips Electronics, where the Optical Inflammation Detection technology was invented.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 9, 2015 | Series B | — | 1 | DFZ Participaties | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
DFZ Participaties | Yes | Series B |